Onychomycosis incidence in type 2 diabetes mellitus patients

Mycopathologia

Volumn 166, Issue 1, 2008, Pages 41-45

  Manzano Gayosso, Patricia ^a   Hernández Hernández, Francisca ^a   Méndez Tovar, Luis Javier ^b   Palacios Morales, Yanni ^c   Córdova Martínez, Erika ^a   Bazán Mora, Elva ^a   López Martinez, Rubén ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b HOSPITAL DE ESPECIALIDADES   (Mexico)

^c Hospital General Dario Fernandez Fierro   (Mexico)

Author keywords

Candida; Dermatophytes; Diabetes mellitus; Onychomycosis

Indexed keywords

ACREMONIUM SP.; ARTHRODERMATACEAE; ASPERGILLUS FUMIGATUS; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CHRYSOSPORIUM; CRYPTOCOCCUS ALBIDUS; CRYPTOCOCCUS LAURENTII; KODAMAEA OHMERI; PICHIA; SCOPULARIOPSIS BREVICAULIS; TRICHOPHYTON RUBRUM; TRICHOSPORON ASAHII;

EID: 46249124834     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-008-9112-5     Document Type: Article

References (28)

1. Pardo-Costello V, Pardo OA. Diseases of the nails. Springfield, IL: Charles C. Thomas; 1960.
2. Elewski BE, Charif MA. Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions. Arch Dermatol 1997;133:1172-3.
3. Gupta AK, Konnikov N, MacDonald P, Rich P, Rodger NW, Edmonds MW, et al. Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey. Br J Dermatol 1998;139:665-71.
4. Perez MI, Kohn SR. Cutaneous manifestations of diabetes mellitus. J Am Acad Dermatol 1994;30:519-51.
5. López González V, Mayorga J. Frecuencia de onicomicosis podal y tiña de los pies en 100 pacientes diabéticos tipo 2. Dermatología Rev Mex 2002;46:254-9.
6. Alvarez MI, González LA, Castro LA. Onychomycosis in Cali, Colombia. Mycopathologia 2004;158:181-6.
7. Ilkit M. Onychomycosis in Adana, Turkey: a 5-year study. Int J Dermatol 2005;44:851-4.
8. López-Martínez R, Hernández-Hernández F, Manzano-Gayosso P, Bazán-Mora E, Romero-Martínez R. Onicomicosis. Diagnóstico etiológico y frecuencia en 282 casos. Rev Mex Patol Clin 1994;41:56-9.
9. Baran R, Hay RJ, Tosti A, Haneke R. A new classification of onychomycosis. Br J Dermatol 1998;139:567-71.
10. Faergemann J, Baran R. Epidemiology, clinical presentation and diagnosis of onychomycosis. Br J Dermatol 2003;149(Suppl 65):1-4.
11. Alteras I, Saryt E. Prevalence of pathogenic fungi in the webs and toenails of diabetic patients. Mycopathologia 1979;67:157-9.
12. Membreño Mann JP, Zonana Nacah A. Hospitalización de pacientes con diabetes mellitus. Causa, complicaciones y mortalidad. Rev Med IMSS 2005;43:97-101.
13. Kane J, Summerbell R, Sigler L, Krajden S, Land G. Laboratory handbook of dermatophytes. Belmont, USA: Star Publishing Company; 1997.
14. Odds FC, Bernaerts R. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol 1994;32:1923-9.
15. Staib P, Morschhauser J. Chlamydospore formation on Staib agar as a species specific characteristic of Candida dubliniensis. Mycoses 1999;42:521-4.
16. Mosca CO, Moragues MD, Llovo J, AI Mosaid A, Coleman DC, Ponton J. Casein agar: a useful medium for differentiating Candida dubliniensis from Candida albicans. J Clin Microbiol 2003;41:1259-62.
17. Khan ZU, Ahmad S, Mokaddas E, Chandy R. Tobacco agar, a new medium for differentiating Candida dubliniensis from Candida albicans. J Clin Microbiol 2004;42:4796-8.
18. Gales AC, Pfaller MA, Houston AK, Joly S, Sullivan DJ, Coleman DC, et al. Identification of Candida dubliniensis based on temperature and utilization of xylose and alpha-methyl-d-glucoside as determined with the API 20 C AUX and vitek YBC systems. J Clin Microbiol 1999;12:3804-8.
19. Rich P. Special patient populations: onychomycosis in the diabetic patients. J Am Acad Dermatol 1996;35(pt 2):S10-2.
20. Levy LA. Epidemiology of onychomycosis in special-risk populations. J Am Podiatr Med Assoc 1997;87:546-50.
21. McCarthy DJ, Boyko EJ, Smith DG. Cutaneous manifestations of the lower extremities in diabetes mellitus. In: Kominsky S, editor. Medical and surgical management of the diabetic foot. St. Louis: Mosby; 1994. p. 191-222.
22. Arenas R, Rubalcaba Priego J, Leyva Santiago J, Álvarez Zavala B, Fabian San Miguel G, Rubalcaba Priego MA, et al. Onicomicosis y diabetes mellitus tipo 2. Frecuencia en 143 pacientes ambulatorios. Dermatología Rev Mex 1999;43:1-7.
23. Piérard GE, Piérard-Franchimont C. The nail under fungal siege in patients with type II diabetes mellitus. Mycoses 2005;48:339-42.
24. Romano C, Gianni C, Difonzo EM. Retrospective study of onychomycosis in Italy: 1985-2000. Mycoses 2005;48:42-4.
25. Méndez-Tovar LJ, Anides-Fonseca A, Vázquez-Hernández A, Galindo-González M, Díaz-Madrid M, Berdón-Castro A, et al. Micosis observadas en cinco comunidades mexicanas con alto grado de marginación. Gac Méd Méx 2006;142:381-6.
26. Mügge C, Haustein UF, Nenoff P. Causative agents of onychomycosis-a retrospective study. J Dtsch Dermatol Ges 2006;4:218-28.
27. Tosti A, Piraccini BM, Lorenzi S. Onychomycosis caused by nondermatophytic molds: clinical features and response to treatment of 59 cases. J Am Acad Dermatol 2000;42:217-24.
28. Gupta AK, Ryder JE, Baran R, Summerbell RC. Non-dermatophyte onychomycosis. Dermatol Clin 2003;21:257-68.